Skip to main content
Clinical Trials/NCT02916225
NCT02916225
Completed
Not Applicable

High Intensity Interval Training Versus Moderate Continuous Training in Heart Failure With Preserved Ejection Fraction Patients: a Randomized Study.

Hospital de Clinicas de Porto Alegre1 site in 1 country19 target enrollmentJune 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Hospital de Clinicas de Porto Alegre
Enrollment
19
Locations
1
Primary Endpoint
Maximal Oxygen Consumption
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to determine whether high intensity interval training (HIIT) is superior to moderate continuous training in increasing cardiopulmonary capacity in heart failure with preserved ejection fraction patients.

Detailed Description

High intensity interval training (HIIT) has been proved to increase oxygen consumption, having superior cardiovascular effect when compared to moderate continuous training (MCT) in post-infarction patients (Wisloff et al.) Aerobic training also had shown positive effect on oxygen consumption and diastolic function in subjects with HFPEF when compared to usual care (Edelmann et al). However, the comparison of HIIT and MCT on improving functional capacity and diastolic function in HFPEF patients has not yet been study.

Registry
clinicaltrials.gov
Start Date
June 2014
End Date
March 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ricardo Stein

Assistant Professor

Hospital de Clinicas de Porto Alegre

Eligibility Criteria

Inclusion Criteria

  • Patients with heart failure with preserved ejection fraction (HFPEF) of any etiology that have functional class of the New York Heart Association (NYHA) between I and III, left ventricular ejection fraction \> 50% and who meet clinical and echocardiography criteria for HFPEF according to the consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology (Paulus et al.). Patients should be clinical stable for the last 3 months and under optimized pharmacologic treatment, being capable of walking without limitations.

Exclusion Criteria

  • Patients with exercise-induced unstable ventricular arrhythmias, unstable angina, moderate to severe valvular heart disease, severe pulmonary disease, severe anemia, cognitive limitations to understand study protocol, use of pacemaker, autonomic neuropathy, cardiovascular event for less than 3 months, congenital heart disease, terminal illness with less than 1 year of life expectancy, peripheral arterial disease with intermittent claudication or osteoarticular conditions limiting exercise will be excluded.

Outcomes

Primary Outcomes

Maximal Oxygen Consumption

Time Frame: 12 weeks after beginning of training

Secondary Outcomes

  • Diastolic Function(12 weeks after beginning of training)
  • Pulmonary function tests(12 weeks after beginning of training)
  • Respiratory muscle strength(12 weeks after beginning of training)
  • Quality of life(12 weeks after beginning of training)

Study Sites (1)

Loading locations...

Similar Trials